Epigenetics concerns heritable or persistent changes in gene regulation and cellular state that occur without requiring a change to the underlying DNA nucleotide sequence. The term has historical roots in developmental biology and was associated with the relationship between genes and the development of phenotype. Modern usage commonly encompasses molecular mechanisms such as DNA methylation, histone modifications, nucleosome organisation and chromatin-associated regulatory processes, although definitions differ somewhat between research fields.
Epigenetic regulation helps determine which genes are accessible and active in particular cells. Because most differentiated human cells contain essentially the same genomic DNA, differences in gene expression among cell types require regulatory mechanisms that establish and maintain distinct expression states. Epigenetic mechanisms are therefore important for development, cellular identity, genomic stability and responses to environmental signals.
DNA methylation is one of the best-studied epigenetic mechanisms. In mammals, methyl groups are frequently added to cytosine residues at cytosine-phosphate-guanine sites, producing 5-methylcytosine. DNA methylation can influence transcription by affecting transcription-factor binding or by recruiting proteins associated with transcriptionally repressed chromatin. Its effects are context-dependent, however, and methylation does not universally mean that a gene is inactive. DNA methylation patterns are established, maintained and removed through specialised enzymatic processes, with active and passive mechanisms contributing to demethylation. Methylation patterns can change during development, cell differentiation, ageing and disease. Abnormal DNA methylation is particularly important in cancer, where tumour cells can exhibit both inappropriate loss and gain of methylation at different genomic regions.
Histones are proteins around which DNA is organised into nucleosomes. Chemical modifications of histone proteins can influence chromatin structure and the recruitment of regulatory proteins. Commonly studied modifications include acetylation, methylation, phosphorylation and ubiquitination, with their effects depending on the modified residue and surrounding molecular context.
Histone acetylation is often associated with more accessible chromatin because it can reduce interactions between positively charged histone proteins and DNA and recruit regulatory proteins, although the biological outcome depends on the particular site and protein machinery involved. Histone methylation can be associated with either activation or repression depending on which amino acid residue is modified and how many methyl groups are present. Epigenetic regulation is consequently a combinatorial system rather than a simple binary switch controlled by one universal modification.
Chromatin remodelling changes the physical organisation and accessibility of DNA. Nucleosomes can be repositioned, removed or reorganised by ATP-dependent chromatin-remodelling complexes, allowing regulatory proteins to access selected genomic regions. Chromatin can also form higher-order structures through interactions among DNA, histones and numerous associated proteins. Enhancers and promoters can communicate through three-dimensional genome organisation, enabling regulatory elements that are distant in linear DNA sequence to influence transcription.
Epigenetic states are maintained through coordinated interactions among DNA methylation, histone modifications, chromatin remodelers, transcription factors and non-coding RNAs. This means that epigenetic regulation cannot be reduced to a single mechanism or molecular mark. Instead, cellular identity is maintained through networks of regulatory information operating alongside the DNA sequence itself.
Epigenetics is particularly important during development. Early embryonic development involves extensive changes in DNA methylation and chromatin organisation as cells transition between developmental states. As cells differentiate, regulatory mechanisms establish patterns of gene activity that help maintain specialised identities. Genomic imprinting is an important example in which certain genes are expressed preferentially from the maternal or paternal copy because of parent-of-origin-specific epigenetic marking.
X-chromosome inactivation provides another example, in which one X chromosome in many female mammalian cells becomes transcriptionally silenced through a complex epigenetic process. These mechanisms illustrate how genetically similar cells can adopt distinct and stable regulatory states. Errors in epigenetic programming can interfere with development and contribute to congenital and developmental disorders.
Epigenetic regulation can respond to environmental and physiological conditions. Nutrition, hormones, inflammation, cellular stress and other factors can influence molecular pathways that establish or alter epigenetic states. Research has investigated relationships between environmental exposures and DNA methylation or chromatin changes, including potential effects associated with ageing, smoking, metabolic conditions and prenatal exposures. However, an observed epigenetic association does not automatically demonstrate that an environmental exposure caused the change or that the change caused a disease outcome.
Cell composition can strongly affect measurements because different cell types naturally possess different epigenetic profiles. Establishing causal relationships requires carefully controlled experimental designs, appropriate tissue sampling and longitudinal or mechanistic evidence. This distinction is essential because epigenetic research is particularly vulnerable to oversimplified claims about environmental effects.
Epigenetic abnormalities occur in numerous diseases. Cancer can involve altered DNA methylation, histone regulation, chromatin-remodelling proteins and other regulatory mechanisms, producing inappropriate activation or silencing of genes. Some inherited disorders result from defects in proteins responsible for establishing or interpreting epigenetic states. Epigenetic mechanisms also interact with ageing, because many tissues undergo progressive changes in DNA methylation and chromatin organisation across the lifespan. Some epigenetic modifications are reversible, making epigenetic enzymes potential therapeutic targets. Drugs that inhibit particular DNA methyltransferases or histone-modifying enzymes have clinical applications in selected diseases, especially certain cancers. Therapeutic manipulation must nevertheless account for the broad roles of these mechanisms because changing gene regulation can affect many cellular pathways simultaneously.
Epigenetics is distinct from Genetics and Genomics while closely connected to both. A DNA sequence variant changes the underlying nucleotide sequence, whereas an epigenetic change generally alters regulation without changing that sequence. Genomics can measure epigenetic features at genome scale, producing epigenomic datasets. Epigenetic inheritance should also be distinguished from ordinary genetic inheritance: an epigenetic state can sometimes persist through cell divisions and, in limited biological contexts, across generations, but claims about widespread stable transgenerational inheritance in humans require strong evidence.
The common phrase that epigenetics means that experiences simply switch genes on or off is an oversimplification. Gene regulation usually involves graded, context-dependent networks, and epigenetic marks are only one part of those networks. A rigorous understanding therefore treats Epigenetics as molecular regulation of genomic function rather than as an alternative form of DNA sequence inheritance.
